Molecular Pharmacology: 46 (3)

September 01, 1994; Volume 46,Issue 3

You have access
Multiple cyclic nucleotide phosphodiesterases.
J A Beavo, M Conti and R J Heaslip

Molecular Pharmacology September 1994, 46 (3) 399-405;
You have access
Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
M Nieto, E Kennedy, D Goldstein and J H Brown

Molecular Pharmacology September 1994, 46 (3) 406-413;
You have access
The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank

Molecular Pharmacology September 1994, 46 (3) 414-422;
You have access
Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi

Molecular Pharmacology September 1994, 46 (3) 423-430;
You have access
A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
J M Barret, P Calsou, A K Larsen and B Salles

Molecular Pharmacology September 1994, 46 (3) 431-436;
You have access
Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
T Dorai, H Kobayashi, J F Holland and T Ohnuma

Molecular Pharmacology September 1994, 46 (3) 437-444;
You have access
Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret

Molecular Pharmacology September 1994, 46 (3) 445-451;
You have access
Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg

Molecular Pharmacology September 1994, 46 (3) 452-459;
You have access
Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer

Molecular Pharmacology September 1994, 46 (3) 460-469;
You have access
Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
M Yamada, M Yamada, M A Watson and E Richelson

Molecular Pharmacology September 1994, 46 (3) 470-476;
You have access
Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani

Molecular Pharmacology September 1994, 46 (3) 477-484;
You have access
Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
L D Khac, S Naze and S Harbon

Molecular Pharmacology September 1994, 46 (3) 485-494;
You have access
Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey

Molecular Pharmacology September 1994, 46 (3) 495-501;
You have access
Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
C Dettbarn, S Györke and P Palade

Molecular Pharmacology September 1994, 46 (3) 502-507;
You have access
Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
L L Firestone, J K Alifimoff and K W Miller

Molecular Pharmacology September 1994, 46 (3) 508-515;
You have access
Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett

Molecular Pharmacology September 1994, 46 (3) 516-522;
You have access
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom

Molecular Pharmacology September 1994, 46 (3) 523-530;
You have access
Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
K Williams

Molecular Pharmacology September 1994, 46 (3) 531-541;
You have access
Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
M Gyenes, Q Wang, T T Gibbs and D H Farb

Molecular Pharmacology September 1994, 46 (3) 542-549;
You have access
Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence.
J A Clark and S G Amara

Molecular Pharmacology September 1994, 46 (3) 550-557;
You have access
Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
A Gemignani, P Paudice, G Bonanno and M Raiteri

Molecular Pharmacology September 1994, 46 (3) 558-562;
You have access
Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook

Molecular Pharmacology September 1994, 46 (3) 562-567;
You have access
Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada

Molecular Pharmacology September 1994, 46 (3) 568-577;
You have access
Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz

Molecular Pharmacology September 1994, 46 (3) 578-585;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals